PRIA Logo™
119-hres-803119th Congress

Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.

Sponsored By: Representative Rose, John W. [R-TN-6]

Introduced

Summary

Reevaluate the safety of all chemical abortion drugs. This resolution would urge the FDA Director to conduct a full safety review and to publicly release real-world outcomes and complication data for these drugs.

Show full summary
  • Women and girls: it raises concerns about physical and emotional harm and cites independent research claiming serious complications are about 22 times higher than currently reported.
  • Patients and providers: it notes chemical abortions now make up more than half of all abortions in the United States and that many prescribing providers receive taxpayer funding.
  • FDA and regulators: it would ask the FDA to reevaluate every chemical abortion drug and to publish a full safety review that includes real-world outcomes and complications.
  • States and laws: it highlights the FDA's September 30, 2025 approval of a generic mifepristone and asserts that greater availability could increase abortions and undermine state pro-life laws.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & CoSponsors

Sponsor

Rose, John W. [R-TN-6]

TN • R

Cosponsors

  • Rep. Harshbarger, Diana [R-TN-1]

    TN • R

    Sponsored 10/10/2025

  • Rep. Carter, Earl L. "Buddy" [R-GA-1]

    GA • R

    Sponsored 10/10/2025

  • Rep. LaMalfa, Doug [R-CA-1]

    CA • R

    Sponsored 10/10/2025

  • Rep. Biggs, Sheri [R-SC-3]

    SC • R

    Sponsored 10/10/2025

  • Rep. Moore, Barry [R-AL-1]

    AL • R

    Sponsored 10/10/2025

  • Rep. Hageman, Harriet M. [R-WY-At Large]

    WY • R

    Sponsored 10/10/2025

  • Rep. Grothman, Glenn [R-WI-6]

    WI • R

    Sponsored 10/10/2025

  • Rep. Aderholt, Robert B. [R-AL-4]

    AL • R

    Sponsored 10/17/2025

  • Rep. Harris, Andy [R-MD-1]

    MD • R

    Sponsored 10/28/2025

  • Rep. Guest, Michael [R-MS-3]

    MS • R

    Sponsored 11/4/2025

  • Rep. Cline, Ben [R-VA-6]

    VA • R

    Sponsored 11/4/2025

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation